Rite Aid Corporation (RAD) News

Rite Aid Corporation (RAD): $0.59

0.04 (-6.54%)

POWR Rating

Component Grades








Add RAD to Watchlist
Sign Up

Industry: Medical - Drug Stores




#5 of 5

in industry

Filter RAD News Items

RAD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

RAD News Highlights

  • RAD's 30 day story count now stands at 21.
  • Over the past 28 days, the trend for RAD's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • LI, DOMO and CVS are the most mentioned tickers in articles about RAD.

Latest RAD News From Around the Web

Below are the latest news stories about RITE AID CORP that investors may wish to consider to help them evaluate RAD as an investment opportunity.

REFILE-Rite Aid plans to shut down hundreds of stores in bankruptcy - WSJ

Rite Aid is negotiating with creditors over the terms of a bankruptcy plan that would include liquidating a substantial portion of its more than 2,100 drugstores, the Wall Street Journal reported on Friday, citing people familiar with the talks. Rite Aid did not immediately respond to a Reuters' request for comment. The company operates more than 2,330 stores in 17 U.S. states, although it is much smaller than rivals such as Walgreens Boots Alliance and CVS Health.

Yahoo | September 22, 2023

Rite Aid Plans to Shut Down Hundreds of Stores in Bankruptcy

Rite Aid is negotiating with creditors over the terms of a bankruptcy plan that would include liquidating a substantial portion of its more than 2,100 drugstores, according to people familiar with the talks.

Yahoo | September 22, 2023

Darden Restaurants, Rite Aid, existing home sales: 3 things to watch

Investing.com -- Stocks wobbled after the Federal Reserve kept interest rates steady as expected but signaled another rate increase might be coming as it continues to work on getting inflation back to its 2% target rate.

Yahoo | September 20, 2023

3 Strong Sell Stocks for September 2023

These 3 stocks to avoid aren't offering much right now – except uncertainty and massive risk of potential losses.

Noah Bolton on InvestorPlace | September 15, 2023

Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine

PHILADELPHIA, September 15, 2023--Following FDA authorization and CDC recommendation, Rite Aid (NYSE: RAD) today announced that scheduling is now available for eligible customers seeking the updated COVID-19 (2023-2024) vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. Appointments are available beginning on Friday, September 22.

Yahoo | September 15, 2023

The alarming reason why this popular retailer is on the brink of bankruptcy

In the case of one vital retailer relied upon by many, all three have contributed to its being on the verge of filing for Chapter 11 protection from creditors. Indeed, not every Chapter 11 bankruptcy restructuring progresses to a Chapter 7 liquidation, causing customers to scramble. It operated 700 stores when it filed for bankruptcy in 2018, and less than 20 stores remain following its reemergence out of Chapter 11 bankruptcy last year.

Yahoo | September 12, 2023

Farmer Brothers (FARM) Reports Q4 Loss, Tops Revenue Estimates

Farmer Brothers (FARM) delivered earnings and revenue surprises of -37.70% and 0.35%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | September 12, 2023

5 Stocks to Buy on a Potential Debt Avalanche

We could be on the brink of a debt avalanche as rates climb higher.

Thomas Yeung on InvestorPlace | September 11, 2023

Rite Aid Announces Availability of OTC NARCAN® Nasal Spray at All Locations

PHILADELPHIA, September 11, 2023--Rite Aid (NYSE: RAD) announced today that NARCAN® Nasal Spray, a medication used to reverse the effects of an opioid overdose, is available at all locations nationwide, including Bartell Drugs in the Pacific Northwest. NARCAN® Nasal Spray can be purchased over the counter without a prescription.

Yahoo | September 11, 2023

Rite Aid (RAD) Moves to Buy: Rationale Behind the Upgrade

Rite Aid (RAD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | September 5, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!